Autor(es): Rajah A

Resumo: A patient with severe Guillain-Barré syndrome responded to treatment with high-dose intravenous immunoglobulins. It is suggested, on the basis of recent case reports, that immunoglobulins may have an important rôle in the future treatment of this immune-mediated disease.

Palavras-Chave: Complications; Guillain-Barre syndrome; Immunoglobulins

Imprenta: Anaesthesia, v. 47, n. 3, p. 220-222, 1992

Identificador do objeto digital: 10.1111/j.1365-2044.1992.tb02123.x

Descritores: Guillain-Barre Syndrome - Proteins

Data de publicação: 1992

INDICADORES

ACESSO